<DOC>
	<DOCNO>NCT00191568</DOCNO>
	<brief_summary>A non-randomized phase II study determine efficacy safety combination Gemcitabine Oxaliplatin follow Gemcitabine radiotherapy patient surgically resect pancreatic cancer .</brief_summary>
	<brief_title>Gemcitabine , Oxaliplatin Radiotherapy Treating Patients With Completely Resected Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma pancreas Patient undergone potentially curative resection No previous irradiation plan field Negative pregnancy test child bear woman Nonadenocarcinoma pancreatic cancer Treatment drug within last 30 day receive regulatory approval . Serious systemic disorder Metastatic disease Pregnancy , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>